Experienced in Thymic Epithelial Tumor

Maarten F. Lambrecht

Leuven, VLG, BE 
Experienced in Thymic Epithelial Tumor
Leuven, VLG, BE 
OverviewLocationsClinical Research

Overview

Maarten Lambrecht practices in Leuven, Belgium. Mr. Lambrecht is rated as an Experienced expert by MediFind in the treatment of Thymic Epithelial Tumor. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Non-Small Cell Lung Cancer (NSCLC), Thymic Epithelial Tumor, and Thymectomy.

His clinical research consists of co-authoring 90 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Thymic Epithelial Tumor.

Gender
Male

Locations

Leuven, VLG, Belgium
Other Locations
Université Catholique De Louvain 10 Avenue Hippocrate, Brussels, BRU 1200, Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Evaluation of Treatment Related Toxicity After Radiotherapy for Head and Neck Cancer and Correlation With Dose to Organs at Risk
Evaluation of Treatment Related Toxicity After Radiotherapy for Head and Neck Cancer and Correlation With Dose to Organs at Risk
Enrollment Status: Withdrawn
Publish Date: April 03, 2023
Dose Escalation by Boosting Radiation Dose Within the Primary Tumor on the Basis of a Pre-treatment FDG-PET-CT Scan in Stage IB, II and III NSCLC: a Randomized Phase II Trial
Dose Escalation by Boosting Radiation Dose Within the Primary Tumor on the Basis of a Pre-treatment FDG-PET-CT Scan in Stage IB, II and III NSCLC: a Randomized Phase II Trial
Enrollment Status: Unknown
Publish Date: January 21, 2022
Intervention Type: Radiation
Study Phase: Not Applicable
Detection of Circulating Biomarkers of Immunogenic Cell Death After Radiotherapy and Chemotherapy: An Exploratory Study
Detection of Circulating Biomarkers of Immunogenic Cell Death After Radiotherapy and Chemotherapy: An Exploratory Study
Enrollment Status: Completed
Publish Date: August 21, 2019
Intervention Type: Other
Study Phase: Not Applicable
View 2 Less Clinical Trials

90 Total Publications

The relationship between radiotherapy dose and cognitive outcomes in functional brain network hubs of glioma patients with predominantly left frontal lobe lesions.
The relationship between radiotherapy dose and cognitive outcomes in functional brain network hubs of glioma patients with predominantly left frontal lobe lesions.
Journal: Neuro-oncology advances
Published: August 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Lambrecht's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile